? Immunotherapy Market: $200B+ by 2030 ? CAR-T Therapy: $8B+ Market ? Immune Checkpoint Inhibitors: 50%+ Cancer Response Rates ? FDA 3.0: Human-Relevant Immunotoxicity Testing ? Autoimmune Disease: 80+ Conditions Affecting 5-8% Population ? Immuno-Oncology: Fastest Growing Pharma Segment
? Immunotherapy Market: $200B+ by 2030 ? CAR-T Therapy: $8B+ Market ? Immune Checkpoint Inhibitors: 50%+ Cancer Response Rates ? FDA 3.0: Human-Relevant Immunotoxicity Testing ? Autoimmune Disease: 80+ Conditions Affecting 5-8% Population ? Immuno-Oncology: Fastest Growing Pharma Segment

The Core of Immune Modeling

Premium domain for comprehensive immune system platforms. Position your technology at the center of immunotherapy, autoimmunity, and infectious disease research.

Inquire Now Learn More
IMMUN CORE T B NK M? DC IMMUNE SYSTEM PLATFORM Innate Adaptive
$200B+
Immunotherapy Market by 2030
80+
Autoimmune Diseases
50%
Cancer IO Response Rates
$8B+
CAR-T Therapy Market

Why ImmunCore?

The perfect domain for comprehensive immune system modeling

Full Immune Ecosystem

Model innate and adaptive immunity including T cells, B cells, NK cells, macrophages, and dendritic cells in integrated platforms.

Immuno-Oncology

Premium positioning for CAR-T, checkpoint inhibitors, BiTEs, and tumor microenvironment modeling platforms.

Autoimmune Disease

Model rheumatoid arthritis, lupus, MS, and other autoimmune conditions with patient-derived immune cells.

Vaccine Development

Test vaccine candidates, adjuvants, and immune responses with human-relevant models for accelerated development.

Cytokine Analysis

Real-time cytokine profiling and immune signaling analysis for comprehensive immunomodulator screening.

FDA 3.0 Ready

Human-relevant immune models aligned with FDA Modernization Act for immunotoxicity and efficacy testing.

Own the Core of Immunology

ImmunCore.com positions your platform at the center of the $200B+ immunotherapy revolution.

Contact Us Today
Redirecting to PatientAnalog.com in 20s